Giant Cell Carcinoma — Trials

Giant Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03912818	Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer	terminated	Phase 2	7	Stanford UniversityOTHER	1	Sep 11, 2023	clinicaltrials
NCT00568906	Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma	terminated	—	129	Stanford UniversityOTHER	1	May 2, 2019	clinicaltrials